145 related articles for article (PubMed ID: 10543725)
1. Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats.
Chang FC; Huang YT; Lin HC; Hong CY; Lin JG; Chen KJ
Can J Physiol Pharmacol; 1999 Aug; 77(8):618-24. PubMed ID: 10543725
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive rats.
Huang YT; Tsai JF; Lin HC; Chen CF; Hong CY
Can J Physiol Pharmacol; 1997; 75(10-11):1220-5. PubMed ID: 9431446
[TBL] [Abstract][Full Text] [Related]
3. Portal hypotensive effects of combined terlipressin and DL-028, a synthetic alpha 1 adrenoceptor antagonist administration on anesthetized portal hypertensive rats.
Huang YT; Lin LC; Chern JW; Lin HC; Hong CY
Liver; 1999 Apr; 19(2):129-34. PubMed ID: 10220743
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of chronic tetramethylpyrazine administration on portal hypertensive rats.
Chang FC; Huang YT; Hong CY; Lin JG; Chen KJ
Eur J Gastroenterol Hepatol; 1999 Sep; 11(9):1027-31. PubMed ID: 10503841
[TBL] [Abstract][Full Text] [Related]
5. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
Bernadich C; Bandi JC; Melin P; Bosch J
Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630
[TBL] [Abstract][Full Text] [Related]
6. Acute hemodynamic effects of tetramethylpyrazine and tetrandrine on cirrhotic rats.
Huang YT; Chang FC; Chen KJ; Hong CY
Planta Med; 1999 Mar; 65(2):130-4. PubMed ID: 10193203
[TBL] [Abstract][Full Text] [Related]
7. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
[TBL] [Abstract][Full Text] [Related]
8. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
Moreau R; Cailmail S; Valla D; Lebrec D
Aliment Pharmacol Ther; 1997 Oct; 11(5):993-7. PubMed ID: 9354212
[TBL] [Abstract][Full Text] [Related]
11. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.
Lopez-Talavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
Hepatology; 1996 Jun; 23(6):1616-21. PubMed ID: 8675185
[TBL] [Abstract][Full Text] [Related]
13. Effects of prostacyclin inhibition on splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
Wang SS; Chu CJ; Lee FY; Wu SL; Lin HC; Chan CC; Chang FY; Lee SD
Scand J Gastroenterol; 2000 Apr; 35(4):426-32. PubMed ID: 10831268
[TBL] [Abstract][Full Text] [Related]
14. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV
J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats.
Oberti F; Veal N; Kaassis M; Pilette C; Rifflet H; Trouvé R; Calès P
J Hepatol; 1998 Jul; 29(1):103-11. PubMed ID: 9696498
[TBL] [Abstract][Full Text] [Related]
16. Amiloride reduces portal hypertension in rat liver cirrhosis.
Steib CJ; Hennenberg M; Beitinger F; Hartmann AC; Bystron M; De Toni EN; Gerbes AL
Gut; 2010 Jun; 59(6):827-36. PubMed ID: 20551467
[TBL] [Abstract][Full Text] [Related]
17. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
Wang CT; Kuang YL; Chen ZP
Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
[TBL] [Abstract][Full Text] [Related]
18. Propranolol modulates the collateral vascular responsiveness to vasopressin via a G(α)-mediated pathway in portal hypertensive rats.
Lee JY; Huo TI; Huang HC; Lee FY; Lin HC; Chuang CL; Chang CC; Wang SS; Lee SD
Clin Sci (Lond); 2011 Dec; 121(12):545-54. PubMed ID: 21736560
[TBL] [Abstract][Full Text] [Related]
19. Effects of different infusion volumes on hemodynamics of portal hypertension canines after hemorrhagic shock.
Li XQ; Dong L; Luo JY
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):571-6. PubMed ID: 15567747
[TBL] [Abstract][Full Text] [Related]
20. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients.
Colle I; De Vriese AS; Van Vlierberghe H; Lameire NH; DeVos M
Liver Int; 2004 Feb; 24(1):63-8. PubMed ID: 15102002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]